Skip to main content

Table 2 AGREE II domain scores of included CPGs for NMIBC

From: Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations

Guideline ID

Domain Score (%)

Scope and purpose

Stakeholder involvement

Rigour of development

Clarity of presentation

Applicability

Editorial independence

ESMO, 2014 [8]

29.17

22.22

19.27

75.00

34.38

35.42

NICE, 2015 [9]

86.11

97.22

76.04

91.67

81.25

87.50

CUA, 2015 [10]

54.17

27.78

44.79

75.00

22.92

33.33

AUA/SUO, 2016 [3]

69.44

43.06

55.21

79.17

22.92

75.00

JUA, 2016 [11]

69.44

41.67

27.08

81.94

22.92

70.83

EAU, 2018 [12]

76.39

75.00

65.63

93.06

44.79

85.42

ICUD/SIU, 2018 [13]

48.61

30.56

21.88

66.67

14.58

52.08

CRHA/CPAM, 2018 [14]

81.94

76.39

66.67

80.56

40.63

85.42

NCCN, 2019 [15]

56.94

41.67

48.96

86.11%

38.54

20.83

ICC (mean ± SD)

0.94 ± 0.05

0.97 ± 0.02

0.97 ± 0.02

0.81 ± 0.15

0.91 ± 0.07

0.91 ± 0.07

Median score (IQR)

69.44

41.67

48.96

80.56

34.38

70.83

(54.17, 76.39)

(30.56, 75.00)

(27.08, 65.63)

(75.00, 86.11)

(22.92, 40.63)

(35.42, 85.42)

  1. IQR Interquartile range